CDKN2A and cancer: Cell senescence is one of the hallmarks where cancer and aging are fundamentally different as accumulating DNA damage usually will cause a upregulation of cell cycle inhibitors leading to senescence or apoptosis while malignant cells avoid this by generating additional mutations such as deletion of tumor suppressors such as p16INK4a or p53, an example of antagonistic pleiotrophy.